Position in DHR
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$6,806,071
-$4,861,981 QoQ
Shares Held
35,897
-29.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $198,707,066 across 6 Diagnostics & Research names. DHR ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
447,274 | $87,656,758 | |
| 2 | NTRA |
Natera, Inc.
|
191,245 | $38,247,087 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
68,477 | $33,658,499 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
122,020 | $20,809,290 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
24,010 | $11,529,361 | |
| 6 | DHR |
Danaher Corp /De/
This page
|
35,897 | $6,806,071 |
All Filings in DHR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,806,071 | 35,897 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,668,052 | 50,970 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $13,012,596 | 65,634 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $37,571,712 | 190,198 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $13,225,370 | 64,514 | Shares | Sole | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||